ProPhase Labs Approves 1-For-10 Reverse Stock Split, Effective December 22, 2025

 

On November 30, 2025, the Company's stockholders approved an amendment to the Company's Certificate of Incorporation to effect a reverse stock split of the Company's common stock at a ratio of one (1) shares for every ten (10) shares of common stock outstanding. The amendment became effective on December 2, 2025.

 

The reverse stock split was implemented to increase the per-share trading price of the Company's common stock to meet continued listing requirements. As a result of the reverse stock split, every ten (10) shares of the Company's common stock issued and outstanding immediately prior to the effective time were automatically combined and converted into one (1) share of common stock.

 

The reverse stock split affected all stockholders uniformly and did not alter any stockholder's percentage ownership interest in the Company, except to the extent that the reverse stock split resulted in any stockholder receiving cash in lieu of fractional shares. No fractional shares were issued in connection with the reverse stock split. Stockholders who would otherwise be entitled to receive fractional shares were rounded up to the nearest whole share.

 

The par value of the Company's common stock remained unchanged at $0.0005 per share. The Company's common stock continues to trade on NASDAQ under the symbol "PRPH".